LYEL vs RIDE
Lyell Immunopharma Inc (LYEL) versus RIDE (RIDE) — a side-by-side from cached financials, not a winner call.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
RIDE (RIDE) common stock.
Latest reported LYEL revenue for 2026-06-30 was $6.0K. Net income was -$68.9M. LYEL currently screens at market cap $143.5M.
RIDE does not have a complete income-statement cache yet.
LYEL currently screens at market cap $143.5M.
Not investment advice. Open the LYEL and RIDE stock pages for the full models.
Not investment advice.